Related Experiment Video
Updated: May 22, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Epigenetic inactivation of DNA repair in breast cancer
Somaira Nowsheen1, Khaled Aziz, Phuoc T Tran
1Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL 35294, USA.
Abstract:
The study of epigenetic mechanisms in cancer, such as DNA methylation and histone modifications, has revealed a plethora of events that contribute to cancer through stable changes in the expression of genes critical to transformation pathways. In this mini review we look at the different epigenetic modifications prevalent in this neoplastic phenotype, focusing on breast cancer. Most encouragingly, research in epigenetics has led to improved survival of patients with certain forms of lymphoma and leukemia through the use of drugs that alter DNA methylation and histone acetylation. Thus, we look at the clinical utility of targeting epigenetic pathways. In addition, we explore numerous other clinical applications of epigenetics, in areas such as cancer screening and early detection, prevention, classification for epidemiology and prognostic purposes, and predicting outcomes after standard therapy.
Insights
Epigenetic modifications like DNA methylation are key in cancer development, especially breast cancer. Targeting these epigenetic pathways offers promising clinical applications for cancer treatment and early detection.
Area of Science:
- Oncology
- Epigenetics
Background:
- Epigenetic mechanisms, including DNA methylation and histone modifications, play a crucial role in cancer development by altering gene expression.
- These modifications are prevalent in neoplastic phenotypes, with a specific focus on breast cancer in this review.
Purpose of the Study:
- To review epigenetic modifications in cancer, particularly breast cancer.
- To explore the clinical utility of targeting epigenetic pathways in cancer therapy.
- To discuss other clinical applications of epigenetics in cancer management.
Main Methods:
- Mini-review of existing literature on epigenetic mechanisms in cancer.
- Focus on DNA methylation and histone modifications.
- Examination of clinical applications and patient outcomes.
Main Results:
- Epigenetic alterations are integral to cancer transformation pathways.
- Drugs targeting DNA methylation and histone acetylation have improved survival in certain leukemias and lymphomas.
- Epigenetics holds potential for cancer screening, early detection, prevention, and prognosis.
Conclusions:
- Targeting epigenetic pathways represents a significant therapeutic strategy in oncology.
- Epigenetic modifications are crucial for understanding and managing various cancers, including breast cancer.
- Further research into clinical applications of epigenetics can enhance cancer patient outcomes.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...

